Search
benzathine penicillin (Bicillin L-A)
Tradename: Bicillin L-A. 1st generation penicillin.
Indications:
1) active against most gram positive organisms, especially Streptococcus species
2) active against Neisseria gonorrhoeae
3) active against some anaerobes
4) active against some spirochetes
5) treatment of mild to moderately severe infections
6) prophylaxis against susceptible organisms
Dosage:
1) adults:
a) group A streptococcal respiratory tract infection: 1.2 x 10E6 U IM as a single dose
b) prophylaxis of recurrent rheumatic fever: 1.2 x 10E6 U IM every 3-4 weeks, or 600,000 U IM every 2 weeks
c) early syphilis: 2.4 x 10E6 U IM as a single dose
d) syphilis of more than 1 year duration: 2.4 x 10E6 U IM weekly for 3 doses
2) infants & children
a) group A streptococcal respiratory tract infection: 25,000 U/kg IM as a single dose; maximum 1.2 x 10E6 U
b) prophylaxis of recurrent rheumatic fever: 25,000 U/kg IM every 3-4 weeks; maximum 1.2 x 10E6 U
c) early syphilis: 50,000 U/kg IM as a single dose; maximum 2.4 x 10E6 U
d) syphilis of more than 1 year duration: 50,000 U/kg IM weekly for 3 doses; maximum 2.4 x 10E6 U/dose
3) neonates > 1200 g: 50,000 U IM as a single dose
Injection: 600,000 U/mL (2 mL)
Pharmacokinetics:
1) slowly absorbed following IM administration
2) time to peak serum concentration within 12-24 hours
Adverse effects:
1) not common (1-10%)
- local pain
2) uncommon (< 1%)
- thrombophlebitis, convulsions, confusion, drowsiness, fever, rash, electrolyte imbalance, hemolytic anemia, positive direct antiglobulin (Coomb's) test (DAT), myoclonus, acute interstitial nephritis, Jarisch- Herxheimer reaction, hypersensitivity reaction, anaphylaxis
Interactions
drug interactions
General
penicillin G
Properties
MISC-INFO: elimination route KIDNEY
pregnancy-category B
safety in lactation ?
Database Correlations
PUBCHEM correlations
References
- The Pharmacological Basis of Therapeutics, 9th ed.
Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- Kaiser Permanente Northern California Regional Drug
Formulary, 1998
Component-of
Bicillin CR